FDA
-
-
-
-
-
-
-
Amneal Reports First Quarter 2026 Financial Results
-
-
-
-
-
-
-
Amneal Announces $2 Million Donation to Support Patient Access to Essential Medicines During Parkinson’s Awareness Month
-
-
-
-
-
-
-
Amneal Receives U.S. FDA Approval for Epinephrine Injection in Single- and Multi-Dose Vials for U.S. Hospitals
-
-
-
-
-
-
-
Amneal gets FDA approval for first generic iohexol injection
-
-
-
-
-
-
-
Amneal submits biosimilar application for XOLAIR to FDA
-
-
-
-
-
-
-
Amneal Receives U.S. FDA Approval for Risperidone Extended-Release Injectable Suspension
-
-
-
-
-
-
-
Amneal Receives U.S. FDA Approval for Prednisolone Acetate Ophthalmic Suspension
-
322,950 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

